FBL19 Activators
FBL19, an integral component of the cellular machinery, plays a crucial role in various biological processes including protein turnover and cellular response to stress. It belongs to the family of E3 ubiquitin ligases, a group entrusted with tagging superfluous or damaged proteins for degradation, thus maintaining cellular proteostasis. The expression of FBL19 is tightly regulated at the transcriptional level, and certain chemical compounds can induce its expression. Understanding the pathways through which these activators function is pivotal, as it can shed light on the intricate regulatory networks that control protein homeostasis in cells. Activators of FBL19 expression work through diverse mechanisms, each initiating a cascade of intracellular events that converge on the upregulation of this essential protein.
Chemical activators such as forskolin, which raises cAMP levels, indirectly drive the expression of FBL19 by stimulating protein kinase A (PKA), a catalyst for the transcription of numerous genes, including those involved in inflammatory responses. Similarly, substances like sulforaphane engage the antioxidant response element (ARE) pathway, enhancing the transcription of genes that bolster cellular defenses against oxidative stress and may include genes encoding E3 ubiquitin ligases like FBL19. Other compounds, such as the small molecule bortezomib, operate by inhibiting proteasomal degradation, leading to an accumulation of ubiquitinated proteins. This accumulation can trigger a compensatory increase in the transcription of ubiquitin ligases, suggesting a feedback mechanism that strives to restore balance within the protein degradation system. The array of chemicals that can induce FBL19 expression, each through its unique pathway, underscores the complexity and precision of cellular regulatory networks. These insights into the molecular interactions and signaling pathways pave the way for a deeper understanding of cellular homeostasis and the role of FBL19 within this dynamic equilibrium.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Through the activation of protein kinase C, PMA can lead to a transcriptional response that specifically increases the level of E3 ubiquitin ligases, including FBL19. | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
LPS initiates a signaling cascade via toll-like receptors that stimulates the production of pro-inflammatory cytokines, which may include the upregulation of FBL19. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating cAMP, forskolin activates protein kinase A (PKA), which can enhance the transcription of inflammatory response genes, potentially raising FBL19 levels. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone activates glucocorticoid response elements to increase transcription of anti-inflammatory genes, a process that may lead to the upsurge of FBL19 expression. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane triggers the antioxidant response element (ARE) pathway, which promotes transcription of cellular stress response genes, possibly including the upregulation of FBL19. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin's suppression of NF-κB activation could lead to a compensatory increase in the expression of proteins in the NF-κB signaling pathway, potentially stimulating the synthesis of FBL19. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol enhances sirtuin activity, which promotes the expression of genes related to cellular stress resistance, and may lead to the increased production of FBL19. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate's stimulation of detoxification enzyme expression through the ARE pathway may extend to stress-related proteins, promoting the upregulation of FBL19. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
By inhibiting the proteasome, bortezomib may cause a compensatory feedback response that increases the transcription of ubiquitin ligases, including FBL19. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Thalidomide's ability to facilitate the degradation of IκB may activate NF-κB-dependent gene expression, leading to the stimulated production of FBL19. | ||||||